prima biomed to release interim cvac clinical , page-27

Well, it's the only approved cancer immunotherapy, but it's not who we should be comparing PRR too.

NWBO (dendritic GMB vaccine) has gone up around 100% in the last couple of days, most likely based on an announcement regarding the manufacturing approval in Germany at the Fraunhofer Institute.

Sound familiar? Yes, the same institute that manufactures CVac gave Prima a grant.

http://www.izi.fraunhofer.de/zelltechnik-gmp-projekte.html?&L=1&print=1

There are other interesting players researching immunotherapy, and while all quite different to each other and Cvac, I find it more useful to compare Prima to them than DNDN.